Questions (part 2... more to come)21 Feb 2021 09:32
Could you ask what building works are proposed in the car park at Alva as per Crober’s photos today on Twitter.
The site is made up of three separate units, we had two of these units which were connected a few years ago. Early last year we took possession of the third unit as part of our expansion plans. This new unit is where the Government equipment will be used and the work we have commenced is to link this unit to the other two, which will allow easier product flow between buildings
The rights issue outlined an intention to use £2.7m to develop a test for Cryptococcal meningitis and a TB-LAM test to diagnose T.B. in people living with HIV. As no mention of either of these was made in the recent finnCap note, how are these going? Are they still planned or has the cash had to be assigned elsewhere due to the shortfall in revenue and lower than expected cash balance?
Work has commenced on both these projects, they are very much in the early phase and a key first step is to produce raw materials that will provide a competitive edge, that is currently our key focus.
From the RNS of Friday 19th June 2020
" Based on the content output from a presentation organised by the African Society for Laboratory Medicine in February 2020, it is estimated that global demand for CD4 tests in 2023 will be 10 million tests per annum"
Has there been any development in this estimate, what is our expected projected market share, what are we doing at present to further this? For example, inclusion in the national HIV algorithm in Nigeria.
We have mentioned in previous investor presentations that we expect demand for our CD4 test within the next 3 to 5 years to reach between 4 to 6 million tests per annum. This estimate is supplied by CHAI/UNITAID
In the RNS it stated "Potential orders have been delayed due to COVID-19 outbreak and the Company's distributor estimates further progress in late summer 2020." Has there been any further progress?
Unfortunately there hasn’t been any significant progress with this format of the test, although our distributor continues to engage with the Nigerian Ministry of Health.
With reference to the supply agreement with CHAI, " Company now awaits confirmation of demand from eligible countries under the agreement." Any news?
As mentioned in the recent trading update - 7-10 countries are expected to have initiated roll out plans for the test by the financial year-end i.e, March with further countries expected to join the program in Qtr 1.